References
- Benson MD. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle DV, editors. The metabolic basis of inherited disease. 7th ed. New York: McGraw-Hill; 1995. pp 4159–4191.
- Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid Int J Exp Clin Invest 1994;1:119–137.
- Sipe JD, Committee. Revised nomenclature for serum amyloid A (SAA). Amyloid: Int J Clin Exp Invest 1999;6:67–70.
- Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 1998;334:489–503.
- Yamada T, Wada A. Slower clearance of human SAA1.5 in mice: implication for allele specific variation of SAA concentration in human. Amyloid: J Prot Fold Dis 2003;10:147–150.
- Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24–29.
- Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H. A novel alleic variant of serum amyloid A. SAA1g: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic amyloidosis. Hum Mol Genet 1995;4:1083–1087.
- Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, Chen CL, Kamatani N. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999;105:360–366.
- Yamada T, Okuda Y, Takasugi K, Itoh K, Igari J. Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:124–127.
- Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW. The biological and chemical basis for tissue-selective amyloid disease. Cell 2006;121:73–85.
- Yamada T, Wada A, Itoh Y, Itoh K. Serum amyloid A1 alleles and plasma concentration of serum amyloid A. Amyloid: Int J Clin Exp Invest 1999;6:199–204.
- Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta 1994;122:323–329.
- Boren J, Lookene A, Makoveichuk E, Xiang S, Gustafsson M, Liu H, Talmud P, Olivecrona G. Binding of low density lipoproteins to lipoprotein lipase is dependent on lipids but not on apolipoprotein B. J Biol Chem 2001;276:26916–26922.
- Yamada T, Wada A, Itoh K, Igari J. Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes. Scand J Immunol 2000;52:7–12.
- Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD. A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol 1999;155:123–133.
- Patel H, Bramall J, Waters H, De Beer MC, Woo P. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996;318:1041–1049.